Transcriptomic Profiling of Circulating HLA-DR^– Myeloid Cells, Compared with HLA-DR⁺ Myeloid Antigen-presenting Cells

References

• Arts RJ, Joosten LA, van der Meer JW, Netea MG. 2013. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors. J Leukoc Biol. 93(2):209–15.
   PubMed Web of Science ®Google Scholar
• Awad RM, De Vlaeminck Y, Maebe J, Goyvaerts C, Breckpot K. 2018. Turn Back the TIMe: targeting Tumor Infiltrating Myeloid Cells to Revert Cancer Progression. Front Immunol. 9:1977.
   PubMed Web of Science ®Google Scholar
• Bernal-Estevez DA, Garcia O, Sanchez R, Parra-Lopez CA. 2018. Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy. BMC Cancer. 18(1):77.
   PubMedGoogle Scholar
• Chen CY, Chen J, He L, Stiles BL. 2018. PTEN: tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne). 9. doi:https://doi.org/10.3389/fendo.2018.00338
   Google Scholar
• David JM, Dominguez C, Hamilton DH, Palena C. 2016. The IL-8/IL-8R Axis: A Double Agent in Tumor Immune Resistance. Vaccines (Basel). 4. doi:https://doi.org/10.3390/vaccines4030022
   Google Scholar
• Dougan M, Dranoff G, Dougan SK. 2019. GM-CSF, IL-3, and IL-5 Family of Cytokines: regulators of Inflammation. Immunity. 50(4):796–811.
   PubMed Web of Science ®Google Scholar
• Ennaciri J, Girard D. 2009. Immune system: maturation of myeloid cells. Methods Mol Biol. 550:195–203.
   PubMedGoogle Scholar
• Esche C, Stellato C, Beck LA. 2005. Chemokines: key players in innate and adaptive immunity. J Invest Dermatol. 125(4):615–28.
   PubMed Web of Science ®Google Scholar
• Fitzer-Attas CJ, Lowry M, Crowley MT, Finn AJ, Meng F, DeFranco AL, Lowell CA. 2000. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn. J Exp Med. 191(4):669–82.
   PubMed Web of Science ®Google Scholar
• Fu C, Jiang A. 2018. Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment. Front Immunol. 9:3059.
   PubMed Web of Science ®Google Scholar
• Gabrilovich DI, Nagaraj S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 9(3):162–74.
   PubMed Web of Science ®Google Scholar
• Gargett T, Christo SN, Hercus TR, Abbas N, Singhal N, Lopez AF, Brown MP. 2016. GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro. Clin Transl Immunology. 5(12):e119.
   PubMedGoogle Scholar
• Hawwari A, Burrows J, Vadas MA, Cockerill PN. 2002. The human IL-3 locus is regulated cooperatively by two NFAT-dependent enhancers that have distinct tissue-specific activities. J Immunol. 169(4):1876–86.
   PubMed Web of Science ®Google Scholar
• Hegde VL, Singh UP, Nagarkatti PS, Nagarkatti M. 2015. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor gamma in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. J Immunol. 5(11):5211–22.
   Google Scholar
• Huang ZY, Hunter S, Chien P, Kim MK, Han-Kim TH, Indik ZK, Schreiber AD. 2011. Interaction of two phagocytic host defense systems: fcgamma receptors and complement receptor 3. J Biol Chem. 286(1):160–68.
   PubMed Web of Science ®Google Scholar
• Khaled YS, Ammori BJ, Elkord E. 2013. Myeloid-derived suppressor cells in cancer: recent progress and prospects. Immunol Cell Biol. 91(8):493–502.
   PubMed Web of Science ®Google Scholar
• Kirkwood KL, Zhang L, Thiyagarajan R, Seldeen KL, Troen BR. 2018. Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility. Immunological Investigations. 47(8):844–54.
   PubMed Web of Science ®Google Scholar
• Kondratova M, Czerwinska U, Sompairac N, Amigorena SD, Soumelis V, Barillot E, Zinovyev A, Kuperstein I. 2019. A multiscale signalling network map of innate immune response in cancer reveals cell heterogeneity signatures. Nat Commun. 10(1):4808.
   PubMed Web of Science ®Google Scholar
• Krupa A, Fol M, Dziadek BR, Kepka E, Wojciechowska D, Brzostek A, Torzewska A, Dziadek J, Baughman RP, Griffith D, et al. 2015. Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune Response. Mediators Inflamm. 2015:1–11.
   Web of Science ®Google Scholar
• Li B, Xi P, Wang Z, Han X, Xu Y, Zhang Y, Miao J. 2018. PI3K/Akt/mTOR signaling pathway participates in Streptococcus uberis-induced inflammation in mammary epithelial cells in concert with the classical TLRs/NF-kB pathway. Vet Microbiol. 227:103–11.
   PubMed Web of Science ®Google Scholar
• Li H, Sorenson AL, Poczobutt J, Amin J, Joyal T, Sullivan T, Crossno JT Jr., Weiser-Evans MC, Nemenoff RA. 2011. Activation of PPARgamma in myeloid cells promotes lung cancer progression and metastasis. PLoS One. 6(12):e28133.
   PubMed Web of Science ®Google Scholar
• Lindau D, Gielen P, Kroesen M, Wesseling P, Adema GJ. 2013. The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells. Immunology. 138(2):105–15.
   PubMed Web of Science ®Google Scholar
• Malone BM, Tan F, Bridges SM, Peng Z. 2011. Comparison of four ChIP-Seq analytical algorithms using rice endosperm H3K27 trimethylation profiling data. PLoS One. 6(9):e25260.
   PubMed Web of Science ®Google Scholar
• Pang X, Song H, Zhang Q, Tu Z, Niu J. 2016. Hepatitis C virus regulates the production of monocytic myeloid-derived suppressor cells from peripheral blood mononuclear cells through PI3K pathway and autocrine signaling. Clin Immunol. 164:57–64.
   PubMed Web of Science ®Google Scholar
• Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH. 2001. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol. 11(10):764–68.
   PubMed Web of Science ®Google Scholar
• Roe K, Gibot S, Verma S. 2014. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Front Microbiol. 5. doi:https://doi.org/10.3389/fmicb.2014.00627
   Google Scholar
• Saleh R, Elkord E. 2019. Acquired resistance to cancer immunotherapy: role of tumor-mediated immunosuppression. Semin Cancer Biol. doi:https://doi.org/10.1016/j.semcancer.2019.07.017
   PubMed Web of Science ®Google Scholar
• Saleh R, Toor SM, Taha RZ, Al-Ali D, Sasidharan Nair V, Elkord E. 2020. DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR(-) myeloid cells, compared with HLA-DR(+) antigen-presenting cells. Epigenetics. 1–14. doi:https://doi.org/10.1080/15592294.2020.1767373
   Google Scholar
• Sanaei R, Rezaei N, Aghamohammadi A, Delbandi AA, Tavasolian P, Tajik N. 2019. Disturbed Transcription of TLRs’ Negative Regulators and Cytokines Secretion among TLR4- and 9-Activated PBMCs of Agammaglobulinemic Patients. Immunological Investigations. 48(8):860–74.
   PubMed Web of Science ®Google Scholar
• Saraiva DP, Jacinto A, Borralho P, Braga S, Cabral MG. 2018. HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients’ Response to Neoadjuvant Chemotherapy. Front Immunol. 9. doi:https://doi.org/10.3389/fimmu.2018.02605
   Google Scholar
• Sasidharan Nair V, Saleh R, Toor SM, Taha RZ, Ahmed AA, Kurer MA, Murshed K, Alajez NM, Abu Nada M, Elkord E 2020a. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer. Clin Epigenetics. 12(1). doi:https://doi.org/10.1186/s13148-13020-10808-13149
   Google Scholar
• Sasidharan Nair V, Toor SM, Taouk G, Pfister G, Ouararhni K, Alajez NM, Elkord E. 2020b. Pembrolizumab Interferes with the Differentiation of Human FOXP3(+)-Induced T Regulatory Cells, but Not with FOXP3 Stability, through Activation of mTOR. J Immunol. 204:199–211.
   PubMed Web of Science ®Google Scholar
• Schlecker E, Stojanovic A, Eisen C, Quack C, Falk CS, Umansky V, Cerwenka A. 2012. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. J Immunol. 189(12):5602–11.
   PubMed Web of Science ®Google Scholar
• Shaath H, Toor SM, Nair VS, Elkord E, Alajez NM. 2019. Transcriptomic Analyses Revealed Systemic Alterations in Gene Expression in Circulation and Tumor Microenvironment of Colorectal Cancer Patients. Cancers (Basel). 11(12):1994.
   Web of Science ®Google Scholar
• Sinha P, Chornoguz O, Clements VK, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S. 2011. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood. 117:5381–90.
   PubMed Web of Science ®Google Scholar
• Sokol CL, Luster AD. 2015. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol. 7(5):a016303.
   PubMed Web of Science ®Google Scholar
• Song MS, Salmena L, Pandolfi PP. 2012. The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol. 13(5):283–96.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. 2015. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43(D1):D447–452.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. 2014. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 6(10):a016295–a016295.
   PubMed Web of Science ®Google Scholar
• Teresi RE, Waite KA. 2008. PPARgamma, PTEN, and the Fight against Cancer. PPAR Res. 2008:1–6.
   Web of Science ®Google Scholar
• Vandewalle A, Tourneur E, Bens M, Chassin C, Werts C. 2014. Calcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functions. Cell Commun Signal. 12(1):8.
   PubMedGoogle Scholar
• Vergadi E, Ieronymaki E, Lyroni K, Vaporidi K, Tsatsanis C. 2017. Akt Signaling Pathway in Macrophage Activation and M1/M2 Polarization. J Immunol. 198(3):1006–14.
   PubMed Web of Science ®Google Scholar
• Vishnubalaji R, Sasidharan Nair V, Ouararhni K, Elkord E, Alajez NM. 2019. Integrated Transcriptome and Pathway Analyses Revealed Multiple Activated Pathways in Breast Cancer. Front Oncol. 9:910.
   PubMed Web of Science ®Google Scholar
• Weiss-Haljiti C, Pasquali C, Ji H, Gillieron C, Chabert C, Curchod M-L, Hirsch E, Ridley AJ, Hooft van Huijsduijnen R, Camps M, et al. 2004. Involvement of Phosphoinositide 3-Kinase γ, Rac, and PAK Signaling in Chemokine-induced Macrophage Migration. J Biol Chem. 279(41):43273–84.
   PubMed Web of Science ®Google Scholar
• Zhao T, Du H, Blum JS, Yan C. 2016. Critical role of PPARgamma in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis. Oncotarget. 7(2):1529–43.
   PubMedGoogle Scholar
• Zhu J, Paul WE. 2010. Heterogeneity and plasticity of T helper cells. Cell Res. 20(1):4–12.
   PubMed Web of Science ®Google Scholar